ID
38666
Beschrijving
Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma
Trefwoorden
Versies (4)
- 05-11-18 05-11-18 -
- 05-11-18 05-11-18 -
- 04-12-18 04-12-18 -
- 30-10-19 30-10-19 - Sarah Riepenhausen
Houder van rechten
GSK group of companies
Geüploaded op
30 oktober 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837
Concomitant Medications Form
- StudyEvent: ODM
Similar models
Concomitant Medications Form
- StudyEvent: ODM
C1522508 (UMLS CUI-2)
C0013227 (UMLS CUI [1,2])
C0947323 (UMLS CUI [1,2])
C0033080 (UMLS CUI [1,2])
C0013231 (UMLS CUI [2])
C0808070 (UMLS CUI [1,2])
C2603343 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C0549178 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2])
C0439810 (UMLS CUI [1,2])
C0349790 (UMLS CUI [1,2])
C0884980 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Geen commentaren